Piezo1 Channels Contribute to the Regulation of Human Atrial Fibroblast Mechanical Properties and Matrix Stiffness Sensing.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
16 03 2021
Historique:
received: 25 01 2021
revised: 08 03 2021
accepted: 12 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 21 10 2021
Statut: epublish

Résumé

The mechanical environment of cardiac cells changes continuously and undergoes major alterations during diseases. Most cardiac diseases, including atrial fibrillation, are accompanied by fibrosis which can impair both electrical and mechanical function of the heart. A key characteristic of fibrotic tissue is excessive accumulation of extracellular matrix, leading to increased tissue stiffness. Cells are known to respond to changes in their mechanical environment, but the molecular mechanisms underlying this ability are incompletely understood. We used cell culture systems and hydrogels with tunable stiffness, combined with advanced biophysical and imaging techniques, to elucidate the roles of the stretch-activated channel Piezo1 in human atrial fibroblast mechano-sensing. Changing the expression level of Piezo1 revealed that this mechano-sensor contributes to the organization of the cytoskeleton, affecting mechanical properties of human embryonic kidney cells and human atrial fibroblasts. Our results suggest that this response is independent of Piezo1-mediated ion conduction at the plasma membrane, and mediated in part by components of the integrin pathway. Further, we show that Piezo1 is instrumental for fibroblast adaptation to changes in matrix stiffness, and that Piezo1-induced cell stiffening is transmitted in a paracrine manner to other cells by a signaling mechanism requiring interleukin-6. Piezo1 may be a new candidate for targeted interference with cardiac fibroblast function.

Identifiants

pubmed: 33809739
pii: cells10030663
doi: 10.3390/cells10030663
pmc: PMC8002259
pii:
doi:

Substances chimiques

IL6 protein, human 0
Integrin beta1 0
Interleukin-6 0
Ion Channels 0
Itgb1 protein, human 0
PIEZO1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 390939984
Organisme : Deutsche Forschungsgemeinschaft
ID : 422681845
Organisme : European Research Council
ID : 337689
Pays : International

Références

Blood. 2012 Aug 30;120(9):1908-15
pubmed: 22529292
Circ Res. 2016 Jan 22;118(2):311-29
pubmed: 26838316
Biochim Biophys Acta. 2016 Sep;1860(9):1953-60
pubmed: 27288584
Nat Cell Biol. 2007 Sep;9(9):1046-56
pubmed: 17721515
Biophys J. 2011 Nov 2;101(9):2131-8
pubmed: 22067150
J Cell Biol. 2000 Aug 21;150(4):797-806
pubmed: 10953004
Nature. 2018 Feb 22;554(7693):487-492
pubmed: 29469092
Front Aging Neurosci. 2018 Oct 22;10:332
pubmed: 30405400
Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1925-1930
pubmed: 29432180
Genes Dev. 2009 Feb 15;23(4):397-418
pubmed: 19240129
Biophys Rev. 2019 Oct;11(5):795-805
pubmed: 31494839
Nat Rev Mol Cell Biol. 2005 Jan;6(1):56-68
pubmed: 15688067
EMBO Rep. 2013 Dec;14(12):1143-8
pubmed: 24157948
J Mol Cell Cardiol. 2021 May 8;:
pubmed: 33974928
Adv Mater. 2019 May;31(21):e1808050
pubmed: 30924979
Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):E5114-22
pubmed: 25385580
Open Microbiol J. 2011;5:114-8
pubmed: 22114656
Biochim Biophys Acta. 2009 Jun;1790(6):431-44
pubmed: 19289150
Biophys J. 2018 Nov 20;115(10):1966-1980
pubmed: 30473015
Front Physiol. 2020 Jan 10;10:1526
pubmed: 31998137
Front Cell Dev Biol. 2020 May 25;8:334
pubmed: 32671058
Nat Rev Mol Cell Biol. 2014 Dec;15(12):802-12
pubmed: 25355505
J Cell Sci. 2010 Jan 1;123(Pt 1):51-61
pubmed: 20016066
Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2196-203
pubmed: 16473959
Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):2228-2239
pubmed: 31533470
J Am Heart Assoc. 2020 Oct 20;9(19):e017025
pubmed: 32924724
PLoS One. 2017 Sep 21;12(9):e0185125
pubmed: 28934329
BMC Bioinformatics. 2015 Oct 26;16:344
pubmed: 26503371
Trends Pharmacol Sci. 2019 Dec;40(12):956-970
pubmed: 31704174
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
FEBS Open Bio. 2020 Jul;10(7):1210-1218
pubmed: 32421922
Antimicrob Agents Chemother. 1979 Dec;16(6):743-9
pubmed: 533256
J Biomech. 2013 Jul 26;46(11):1967-71
pubmed: 23746597
Nature. 2012 Feb 19;483(7388):176-81
pubmed: 22343900
Annu Rev Biomed Eng. 2005;7:223-53
pubmed: 16004571
Nat Rev Cancer. 2018 Sep;18(9):533-548
pubmed: 30002479
Neuron. 2018 Nov 21;100(4):799-815.e7
pubmed: 30344046
Nano Lett. 2017 Mar 8;17(3):2064-2072
pubmed: 28164706
Biochemistry. 1992 Oct 6;31(39):9421-8
pubmed: 1356435
Biochim Biophys Acta. 2013 Jul;1832(7):884-90
pubmed: 23434892
Science. 2010 Oct 1;330(6000):55-60
pubmed: 20813920
Cell. 2006 Aug 25;126(4):677-89
pubmed: 16923388
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16148-53
pubmed: 25349416
J Cell Biol. 2016 Nov 21;215(4):445-456
pubmed: 27872252
J Clin Invest. 1972 Mar;51(3):598-603
pubmed: 5011102
Cell Signal. 2010 Dec;22(12):1838-48
pubmed: 20667469
Cold Spring Harb Perspect Biol. 2011 Mar 01;3(3):
pubmed: 21421922
Biophys J. 2014 Aug 5;107(3):564-575
pubmed: 25099796
Nat Rev Mol Cell Biol. 2017 Dec;18(12):771-783
pubmed: 28974772
J Cell Mol Med. 2020 Dec;24(23):13853-13862
pubmed: 33124775
Methods Mol Biol. 2020;2173:217-231
pubmed: 32651921
Naunyn Schmiedebergs Arch Pharmacol. 2021 Mar;394(3):533-543
pubmed: 33064167
Front Physiol. 2018 Nov 05;9:1545
pubmed: 30455648
Exp Cell Res. 2019 Jun 1;379(1):119-128
pubmed: 30910400
Adv Mater. 2019 Mar;31(12):e1806727
pubmed: 30687975
J Biol Chem. 2019 Nov 15;294(46):17395-17408
pubmed: 31586031
Commun Biol. 2019 Aug 7;2:298
pubmed: 31396578
J Mol Cell Cardiol. 2016 Apr;93:162-74
pubmed: 26562414
J Cell Biol. 2018 Nov 5;217(11):3776-3784
pubmed: 30254032
J Am Soc Nephrol. 2019 Oct;30(10):1910-1924
pubmed: 31416818

Auteurs

Ramona Emig (R)

Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg Bad Krozingen, and Faculty of Medicine, University of Freiburg, 79110 Freiburg, Germany.
CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany.
Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.

Wiebke Knodt (W)

Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg Bad Krozingen, and Faculty of Medicine, University of Freiburg, 79110 Freiburg, Germany.

Mario J Krussig (MJ)

Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg Bad Krozingen, and Faculty of Medicine, University of Freiburg, 79110 Freiburg, Germany.

Callum M Zgierski-Johnston (CM)

Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg Bad Krozingen, and Faculty of Medicine, University of Freiburg, 79110 Freiburg, Germany.

Oliver Gorka (O)

Institute of Neuropathology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Olaf Groß (O)

Institute of Neuropathology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104 Freiburg, Germany.
Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.

Peter Kohl (P)

Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg Bad Krozingen, and Faculty of Medicine, University of Freiburg, 79110 Freiburg, Germany.
CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany.

Ursula Ravens (U)

Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg Bad Krozingen, and Faculty of Medicine, University of Freiburg, 79110 Freiburg, Germany.

Rémi Peyronnet (R)

Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg Bad Krozingen, and Faculty of Medicine, University of Freiburg, 79110 Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH